The European functional foods market earned $545 million in 2008 and is estimated to earn up to $2 billion in 2014, according to analysis from Frost & Sullivan (Palo Alto, CA), the company reported on January 13.
The European functional foods market earned $545 million in 2008 and is estimated to earn up to $2 billion in 2014, according to analysis from Frost & Sullivan (Palo Alto, CA), the company reported on January 13.
"A variety of ingredients positioned for heart-health, with their functional benefits, is increasingly used for the fortification of various food and beverage applications," said Frost & Sullivan research analyst Chandrasekhar S. "The preventive cost of cardiovascular disease (CVD) by virtue of these ingredients is much cheaper for the consumers than the cost of its treatment."
Nevertheless, the heart health ingredients market is restrained by a 2000 EU food-labeling directive preventing health claims from being made on products.
Nonetheless, European manufacturers have submitted their dossiers to the European Food Safety Authority (EFSA; Parma, Italy) to place health claims on their ingredients.
"Manufacturers, with the help of industry associations such as GOED (Salt Lake City) are lobbying for the usage of health claims," noted Chandrasekhar.
"They are also involved in extensive branding and promotional activities to increase consumer awareness on CVD and the positive impact of the various ingredients, thereby enhancing the credibility of such awareness campaigns."
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.